|Bid||505.10 x 0|
|Ask||515.00 x 0|
|Day's range||499.15 - 499.15|
|52-week range||363.20 - 549.10|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||24 Jan 2023 - 30 Jan 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The Joint's (JYNT) expansionary move is expected to be a prudent one, given the growing demand for affordable and convenient chiropractic care in the region.
Cigna (CI) decides to integrate cost-effective biosimilars within its commercial formularies from next year in a bid to drive pharmacy revenues.
Apple, IBM, Elevance Health, Charter Communications and Archer-Daniels-Midland Company are included in this Analyst Blog.